Himalaya Therapeutics, an India-based clinical-stage biopharmaceutical company, announced on Monday that it has named Brian Zhang, PhD as its new chief executive officer.
Dr Zhang has served Hoffmann-La Roche. He cofounded several biotechnology start-ups and invested in biopharmaceuticals.
Dr Zhang holds a PhD from UCLA School of Medicine and a BS from Nanjing University.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer